Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Asset disposition Quarterly results Acq. announced Director departure Appointed director CC transcript Notes have priced Inv. presentation
|
LIGAND PHARMACEUTICALS INC (LGND)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/11/2020 |
GN
| PFENEX INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Buyout |
02/19/2020 |
GN
| INVESTOR ALERT: BDX LGND LOPE SBT: Kirby McInerney LLP Continues Investigation of Shareholder Claims |
03/05/2019 |
GN
| Detailed Research: Economic Perspectives on Twenty-First Century Fox, Acadia Healthcare, Targa Resources, WellCare Health Plans, Ligand Pharmaceuticals, and Duke Energy — What Drives Growth in Today's Competitive Landscape |
03/04/2019 |
GN
| Sermonix to Present Poster at ENDO 2019 on Lasofoxifene's ‘Potent Anti-Tumor Activity' in ESR1 Hormone-Resistant Breast Cancer |
02/01/2019 |
GN
| Consolidated Research: 2019 Summary Expectations for Micron Technology, Quidel, Ligand Pharmaceuticals, Altra Industrial Motion, USG, and Equity Lifestyle Properties — Fundamental Analysis, Key Performance Indications |
01/29/2019 |
GN
| Bragar Eagel & Squire, P.C. is Investigating Ligand Pharmaceuticals Incorporated (LGND) on Behalf of Stockholders and Encourages LGND Investors to Contact the Firm |
01/24/2019 |
GN
| Seelos Therapeutics, Inc. Announces Successful Completion of its Merger with Apricus Biosciences, Inc. to Advance Late-Stage Pipeline of Products for Central Nervous System (CNS) Disorders |
01/17/2019 |
GN
| Bragar Eagel & Squire, P.C. is Investigating Ligand Pharmaceuticals Incorporated (LGND) on Behalf of Stockholders and Encourages LGND Investors to Contact the Firm |
01/17/2019 |
GN
| SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Ligand Pharmaceuticals Incorporated (LGND) |
11/14/2018 |
GN
| Sermonix Pharmaceuticals to Present Three Posters Focused on Precision Medicine in the Treatment of Metastatic Breast Cancer at San Antonio Breast Cancer Symposium |
10/22/2018 |
GN
| Analysis: Positioning to Benefit within Ligand Pharmaceuticals, AptarGroup, Unifirst, Universal, AutoZone, and Churchill Downs — Research Highlights Growth, Revenue, and Consolidated Results |
10/09/2018 |
GN
| Orchestra BioMed™ Adds Three Industry Leaders to Strategic Advisory Board |
07/30/2018 |
GN
| Apricus Biosciences, Inc. Announces Merger Agreement with Seelos Therapeutics, Inc. to Advance Late-Stage Pipeline of Products for Central Nervous System (CNS) Disorders |
11/22/2017 |
GN
| Detailed Research: Economic Perspectives on MACOM Technology Solutions, Whirlpool, Dril-Quip, Ligand Pharmaceuticals, National CineMedia, and F5 Networks — What Drives Growth in Today's Competitive Landscape |
|
|